All AbMole products are for research use only, cannot be used for human consumption.
Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.
| Molecular Weight | 361.82 |
| Formula | C19H20ClNO4 |
| CAS Number | 41859-67-0 |
| Solubility (25°C) | DMSO 50 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[3] V De Marco, et al. Therapy of Canine Hyperlipidemia with Bezafibrate
[4] No authors listed. Drug Ther Bull. Bezafibrate
[5] E Kanterewicz, et al. Bezafibrate induced rhabdomyolysis
| Related PPAR Products |
|---|
| WY 14643 (Pirinixic Acid)
WY 14643 (Pirinixic Acid) is a potent and selective, peroxisome proliferator-activated receptor-α (PPARα) agonist. |
| GSK 3787
GSK3787 is an orally available selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6). |
| Ciprofibrate
Ciprofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist. |
| ZLN005
ZLN005 is a novel and potent small molecule PGC-1α transcriptional activator. |
| Clofibric Acid (PCIB)
Clofibric acid (PCIB, Chlorofibrinic acid), a lipid fiber modulator Clofibrate, Etofibrate and Etofyllinclofibrate active metabolites, is a PPARα excitant, has the effect of lowering blood lipid. Clofibric acid is also a herbicide. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
